Belluscura (BELL)

Sector:

Health Care

Index:

FTSE AIM All-Share

9.50p
   
  • Change Today:
    -0.50p
  • 52 Week High: 25.50
  • 52 Week Low: 7.25
  • Currency: UK Pounds
  • Shares Issued: 168.41m
  • Volume: 64,457
  • Market Cap: £16.00m
  • Beta: 0.87

Belluscura shares surge on strong sales momentum, improved outlook

By Josh White

Date: Tuesday 27 Aug 2024

LONDON (ShareCast) - (Sharecast News) - Belluscura, a developer of lightweight and portable oxygen enrichment technology, reported strong sales momentum and an optimistic trading outlook on Tuesday, as it prepared for the full commercial launch of its new 'DISCOV-R' portable oxygen concentrator.
The AIM-traded firm, which was holding its annual general meeting, highlighted a significant increase in sales and a positive forecast for the rest of 2024.

It said that it achieved record sales in July, generating $0.71m in revenue, surpassing the previous high of $0.52m set in June.

The company expected the strong sales trajectory to continue, driven by growing market acceptance of its X-PLOR device and the anticipated success of the DISCOV-R, which was introduced to the US market via a soft launch in June.

It said the DISCOV-R portable oxygen concentrator, which weighs just over six pounds, offered 50% more oxygen output than the leading competitor and produced more oxygen by weight than any other portable device on the market.

The strong demand for the DISCOV-R was reportedly evident, with all units produced in June and July already sold.

Belluscura said a full commercial launch of the device was scheduled for the middle of the fourth quarter.

Given the promising market response and the upcoming launch of the DISCOV-R, Belluscura updated its trading outlook for the final months of 2024.

The company said it now anticipated full-year revenue for 2024 to be between $8m and $10m - a substantial increase from $0.83m in 2023.

Furthermore, the company expected to achieve positive EBITDA in the first quarter of the 2025 financial year, with an annualised revenue run rate of $14m to $16m by the end of the year.

To support the ongoing expansion and meet the high customer demand for the DISCOV-R, Belluscura said it was evaluating various financing options, including debt and credit facilities.

The company noted that, while increased sales of the X-PLOR units had reduced raw materials inventory, securing additional funding would be crucial to sustaining the growth of the DISCOV-R.

At 1216 BST, shares in Belluscura were up 43.86% at 15.82p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Belluscura Market Data

Currency UK Pounds
Share Price 9.50p
Change Today -0.50p
% Change -5.00 %
52 Week High 25.50
52 Week Low 7.25
Volume 64,457
Shares Issued 168.41m
Market Cap £16.00m
Beta 0.87

Belluscura Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
8.11% above the market average8.11% above the market average8.11% above the market average8.11% above the market average8.11% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Price Trend
87.95% below the market average87.95% below the market average87.95% below the market average87.95% below the market average87.95% below the market average
78.38% below the sector average78.38% below the sector average78.38% below the sector average78.38% below the sector average78.38% below the sector average
Income Not Available
Growth
5.25% below the market average5.25% below the market average5.25% below the market average5.25% below the market average5.25% below the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average

Belluscura Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
11:51 50,000 @ 9.50p
11:18 1,600 @ 9.70p
10:20 10,000 @ 9.50p
08:45 2,857 @ 9.50p

Belluscura Key Personnel

CEO Robert “Bob” Rauker
CFO Simon Neicheril

Top of Page